Tatva Chintan IPO GMP

Tatva Chintan Pharma Chem Ltd IPO Grey market Price Detail

Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.

Competitive strengths Tatva Chintan Pharma Chem Company

  • Leading manufacturer of structure-directing agents and phase transfer catalyst.
  • Diversified product portfolio.
  • Global market presence with a customer base across industries.
  • Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.
  • Experienced promoters and managers team.
  • Strong financial performance track record.

Tatva Chintan Company Financials:

Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 3,148.03 2,489.38 1,875.08
Total Revenue 3,062.92 2,646.22 2,068.01
Profit After Tax 522.62 377.89 205.43

Tatva Chintan IPO Objects of the Issue:

  • Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
  • Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
  • To meet general corporate purposes.

Tatva Chintan Pharma IPO Details

IPO Opening Date Jul 16, 2021
IPO Closing Date Jul 20, 2021
Issue Type Book Built Issue IPO
Face Value ₹10 per equity share
IPO Price ₹1073 to ₹1083 per equity share
Market Lot 13 Shares
Min Order Quantity 13 Shares
Listing At BSE, NSE
Issue Size [.] Eq Shares of ₹10
(aggregating up to ₹500.00 Cr)
Fresh Issue [.] Eq Shares of ₹10
(aggregating up to ₹225.00 Cr)
Offer for Sale [.] Eq Shares of ₹10
(aggregating up to ₹275.00 Cr)

Grey market premium (GMP) for Tatva Chintan Pharma has risen by 98% to Rs 1,060 ahead of its share allotment that is scheduled for July 26

Tatva Chintan IPO GMP today is ₹1060, which is ₹45 up from its yesterday’s grey market premium of ₹1015.

Tatva Chintan Pharma IPO Tentative Timetable

The Tatva Chintan Pharma IPO open date is Jul 16, 2021, and the close date is Jul 20, 2021. The issue may list on Jul 29, 2021.

IPO Open Date Jul 16, 2021
IPO Close Date Jul 20, 2021
Basis of Allotment Date Jul 26, 2021
Initiation of Refunds Jul 27, 2021
Credit of Shares to Demat Account Jul 28, 2021
IPO Listing Date Jul 29, 2021

Tatva Chintan Pharma IPO Lot Size

The Tatva Chintan Pharma IPO market lot size is 13 shares. A retail-individual investor can apply for up to 14 lots (182 shares or ₹197,106).

Application Lots Shares Amount (Cut-off)
Minimum 1 13 ₹14,079
Maximum 14 182 ₹197,106

Tatva Chintan Pharma IPO Promoter Holding

Pre Issue Share Holding 100%
Post Issue Share Holding 79.17%

Leave a Reply

Your email address will not be published. Required fields are marked *